Flagship explainer
What drives INTELLIA THERAPEUTICS, INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$413M | FY2025 |
| |
| Income before tax | −$413M | FY2025 |
|
| Operating income | −$441M | FY2025 |
|
| $67.7M | FY2025 |
| |
| Ending assets | $842M | FY2025 |
|
| Beginning assets | $1.2B | FY2024 |
|
| $671M | FY2025 |
| |
| $872M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001193125-26-076550